Boston Scientific Analysts Cut Their Forecasts Following Q4 Results

Core Insights - Boston Scientific Corporation reported strong fourth-quarter earnings for 2025, with revenues of $5.29 billion, slightly above the consensus estimate of $5.28 billion and exceeding management guidance of $5.22 billion to $5.31 billion [1] - The company achieved adjusted earnings of 80 cents per share, surpassing the consensus of 78 cents and management guidance of 77 to 79 cents [1] Revenue Forecast - For 2026, Boston Scientific forecasts net sales growth of approximately 10.5% to 11.5% on a reported basis and 10% to 11% organically, with expected sales between $22.18 billion and $22.38 billion, compared to the consensus of $22.37 billion [2] - The company estimates adjusted earnings per share for 2026 to be between $3.43 and $3.49, against the consensus of $3.47 [2] Market Reaction - Following the earnings announcement, Boston Scientific shares increased by 0.6%, reaching $75.92 in pre-market trading [2] - Analysts have adjusted their price targets for Boston Scientific in response to the earnings results [3]